NO952175L - Nukleotidsekvens som koder for karbamoylfosfatsyntetitase II - Google Patents
Nukleotidsekvens som koder for karbamoylfosfatsyntetitase IIInfo
- Publication number
- NO952175L NO952175L NO952175A NO952175A NO952175L NO 952175 L NO952175 L NO 952175L NO 952175 A NO952175 A NO 952175A NO 952175 A NO952175 A NO 952175A NO 952175 L NO952175 L NO 952175L
- Authority
- NO
- Norway
- Prior art keywords
- carbamoyl phosphate
- sequence encoding
- nucleotide sequence
- synthetitase
- phosphate synthetase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
- C12Y603/05—Carbon-nitrogen ligases with glutamine as amido-N-donor (6.3.5)
- C12Y603/05005—Carbamoyl-phosphate synthase (glutamine-hydrolysing) (6.3.5.5)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPL620692 | 1992-12-03 | ||
| AUPL638092 | 1992-12-16 | ||
| PCT/AU1993/000617 WO1994012643A1 (en) | 1992-12-03 | 1993-12-02 | Nucleotide sequence encoding carbamoyl phosphate synthetase ii |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO952175D0 NO952175D0 (no) | 1995-06-01 |
| NO952175L true NO952175L (no) | 1995-06-01 |
Family
ID=25644386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO952175A NO952175L (no) | 1992-12-03 | 1995-06-01 | Nukleotidsekvens som koder for karbamoylfosfatsyntetitase II |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5849573A (es) |
| EP (1) | EP0675958A4 (es) |
| JP (1) | JPH08503607A (es) |
| KR (1) | KR950704495A (es) |
| CN (1) | CN1041535C (es) |
| AP (1) | AP429A (es) |
| BR (1) | BR9307584A (es) |
| CA (1) | CA2150572A1 (es) |
| FI (1) | FI952697A (es) |
| HU (2) | HUT71930A (es) |
| IL (1) | IL107845A0 (es) |
| MX (1) | MX9307662A (es) |
| MY (1) | MY109022A (es) |
| NO (1) | NO952175L (es) |
| OA (1) | OA10163A (es) |
| PL (1) | PL309261A1 (es) |
| WO (1) | WO1994012643A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6468765B1 (en) * | 1995-04-21 | 2002-10-22 | Human Genome Sciences, Inc. | Selected Haemophilus influenzae Rd polynucleotides and polypeptides |
| AU3984497A (en) * | 1996-08-16 | 1998-03-06 | Innovir Laboratories, Inc. | Phenotypic conversion of cells mediated by external guide sequences |
| US6610478B1 (en) | 1996-08-16 | 2003-08-26 | Yale University | Phenotypic conversion of cells mediated by external guide sequences |
| EP1082414A1 (en) * | 1998-06-01 | 2001-03-14 | Incyte Pharmaceuticals, Inc. | Carbamoyl phosphate synthase homolog |
| CN100510079C (zh) * | 2001-04-04 | 2009-07-08 | 中国医学科学院基础医学研究所 | 恶性疟原虫蛋白基因 |
| CN100510080C (zh) * | 2001-04-04 | 2009-07-08 | 中国医学科学院基础医学研究所 | 恶性疟原虫新的抗原候选基因PfMAg |
| CN1316015C (zh) * | 2001-08-03 | 2007-05-16 | 味之素株式会社 | 新突变型氨甲酰磷酸合成酶以及生产由氨甲酰磷酸衍生的化合物的方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5585479A (en) * | 1992-07-24 | 1996-12-17 | The United States Of America As Represented By The Secretary Of The Navy | Antisense oligonucleotides directed against human ELAM-I RNA |
-
1993
- 1993-12-01 AP APAP/P/1994/000607A patent/AP429A/en active
- 1993-12-02 JP JP6512592A patent/JPH08503607A/ja not_active Ceased
- 1993-12-02 US US08/446,855 patent/US5849573A/en not_active Expired - Fee Related
- 1993-12-02 CA CA002150572A patent/CA2150572A1/en not_active Abandoned
- 1993-12-02 WO PCT/AU1993/000617 patent/WO1994012643A1/en not_active Application Discontinuation
- 1993-12-02 PL PL93309261A patent/PL309261A1/xx unknown
- 1993-12-02 EP EP94900652A patent/EP0675958A4/en not_active Ceased
- 1993-12-02 HU HU9501583A patent/HUT71930A/hu unknown
- 1993-12-02 KR KR1019950702245A patent/KR950704495A/ko not_active Application Discontinuation
- 1993-12-02 MY MYPI93002571A patent/MY109022A/en unknown
- 1993-12-02 BR BR9307584-7A patent/BR9307584A/pt not_active Application Discontinuation
- 1993-12-02 IL IL10784593A patent/IL107845A0/xx unknown
- 1993-12-03 MX MX9307662A patent/MX9307662A/es unknown
- 1993-12-03 CN CN93121697A patent/CN1041535C/zh not_active Expired - Fee Related
-
1995
- 1995-06-01 NO NO952175A patent/NO952175L/no unknown
- 1995-06-02 OA OA60671A patent/OA10163A/en unknown
- 1995-06-02 FI FI952697A patent/FI952697A/fi not_active Application Discontinuation
- 1995-06-20 HU HU95P/P00284P patent/HU211526A9/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1041535C (zh) | 1999-01-06 |
| BR9307584A (pt) | 1999-08-31 |
| JPH08503607A (ja) | 1996-04-23 |
| CA2150572A1 (en) | 1994-06-09 |
| NO952175D0 (no) | 1995-06-01 |
| AP9400607A0 (en) | 1994-01-31 |
| MX9307662A (es) | 1994-06-30 |
| FI952697A0 (fi) | 1995-06-02 |
| WO1994012643A1 (en) | 1994-06-09 |
| OA10163A (en) | 1996-12-18 |
| EP0675958A1 (en) | 1995-10-11 |
| MY109022A (en) | 1996-11-30 |
| EP0675958A4 (en) | 1997-10-22 |
| KR950704495A (ko) | 1995-11-20 |
| HUT71930A (en) | 1996-02-28 |
| HU211526A9 (en) | 1995-11-28 |
| US5849573A (en) | 1998-12-15 |
| FI952697A (fi) | 1995-07-14 |
| CN1090327A (zh) | 1994-08-03 |
| AP429A (en) | 1995-11-09 |
| IL107845A0 (en) | 1994-04-12 |
| HU9501583D0 (en) | 1995-08-28 |
| PL309261A1 (en) | 1995-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL148152A0 (en) | Sequence-specific dna recombination in eukaryotic cells | |
| WO1995007718A3 (en) | Purine nucleoside phosphorylase gene therapy for human malignancy | |
| Switchenko et al. | Intermediates in the enzymic synthesis of tetrahydrobiopterin in Drosophilamelanogaster | |
| AU2270899A (en) | Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments | |
| NO952175L (no) | Nukleotidsekvens som koder for karbamoylfosfatsyntetitase II | |
| Miller et al. | Purine and pyrimidine metabolizing activities in Trichomonas vaginalis extracts | |
| Wang et al. | Salvage of pyrimidine nucleosides by Trichomonas vaginalis | |
| AU8148894A (en) | Therapy | |
| Senesi et al. | A specific adenosine phosphorylase, distinct from purine nucleoside phosphorylase | |
| DK393089D0 (da) | Dna omfattende samvirkende biosyntesegener og fremgangsmaade til oegning af produktion af sekundaere metabolitter under anvendelse af dette | |
| AU2002303437A1 (en) | Isolation of neural stem cells using gangliosides and other surface markers | |
| EP0293193A3 (en) | Gene transfer for drug resistance | |
| Hartman et al. | PROTEINASE BIOSYNTHESIS BY STREPTOCOCCUS LIQUEFACIENS: II. PURINE, PYRIMIDINE, AND VITAMIN REQUIREMENTS | |
| NO20016270D0 (no) | Vektorer, celler og fremgangsmåter for fremstilling av pyrimidindeoksyribonukleosider | |
| YU26995A (sh) | Postupak za pripremanje 2-amino-4,6-dihloro-pirimidina | |
| ES2016227A4 (es) | 54- procedimiento para la elaboracion de aminoacidos l-alfa. | |
| ATE42341T1 (de) | Herstellung von uridin. | |
| Wang et al. | Tritrichomonas foetus: partly defined cultivation medium for study of the purine and pyrimidine metabolism | |
| WO2001025415A3 (de) | Gentransfer in humane lymphocyten mittels retroviraler scfv-zelltargeting vektoren | |
| Fox et al. | AICAR is not an endogenous mutagen in Escherichia coli | |
| AU2001286506A1 (en) | Isolated mammalian neural stem cells, methods of making such cells, and methods of using such cells | |
| EP1806405A3 (en) | Vectors, cells and processes for pyrimidine deoxyribonucleosides production | |
| Hirayama et al. | Regulation of tetrahydrobiopterin biosynthesis in cultured hypothalamic and mesencephalic neurons by cyclic AMP dependent GTP cyclohydrolase I gene expression | |
| Lawrence et al. | Further studies of the action of methionyl adenylate on chick embryo fibroblasts | |
| DK490588A (da) | Gaerstammer, som giver en foroeget fermenteringshastighed af sukker, deres fremstilling og anvendelse |